The Optchain™ platform acts as a 360-degree supply chain control tower. Any type of granular data can be created, captured and connected throughout the supply chain thanks to OPTEL’s portfolio of products. It provides unprecedented, end-to-end visibility and transparency, from raw materials to end users to how they are recycled or disposed of.

Optchain™ boasts industry-leading traceability capabilities to help businesses have more high-performance and sustainable supply chains as well as comply with local regulations and international standards. As a traceability and decision-making solution, Optchain™ plays a critical role in the healthcare and pharmaceutical industries to monitor and track drugs, ensuring their proper use and safeguarding patients.

CHALLENGES

  • CGT organizations want to create and share data across their supply chain, such as CoI/CoC information, environmental temperature conditions, security and location of material, etc. to streamline operations and ensure regulatory compliance.
  • Once an organization selects one cell orchestration system, all other stakeholders in their supply chain need the same system.
  • Organizations will need to use multiple orchestration systems for different products and different stakeholders.
  • This drastically increases the complexity of the supply chain ecosystem, with a proliferation integration requirements, expertise and maintenance

KEY BENEFITS

Optchain™ is a decentralized open-data platform that can connect existing interfaces, creating a connected, real-time industry network.

  • Seamless interoperability
  • Based on GS1 standards
  • Interface-agnostic to facilitate onboarding and use
  • Competitive business model

 

Contact Us

WHAT OPTEL’S TRACEABILITY SOLUTIONS CAN DO FOR YOUR BUSINESS

  • Improve Operational Intelligence

    Improve Operational Intelligence

  • Easily Achieve Pharmaceutical Compliance

    Achieve Pharmaceutical Compliance

  • Increase Product Safety

    Increase Product Safety

  • Secure Supplies

    Secure Supplies

  • Disclose Transparency

    Disclose Transparency

Advanced Therapy Medicinal Products

THE CELL AND GENE THERAPY INDUSTRY IS AN ECOSYSTEM OF DIVERSE STAKEHOLDERS

The cell and gene therapy ecosystem is comprised of stakeholders from different fields and specialities, including research, manufacturing and healthcare. There is a mutual dependence between these organizations to develop, product and deliver safe products to patients. The level of involvement of each stakeholder in the cell and gene therapy ecosystem can depend on what stage of the product lifecycle the drug is, such as discovery, clinical and commercial phases, and information sharing is critical throughout each phase and as supply chains evolve.

 

Advanced Therapy Medicinal Products

MULTIPLE SILOED ORCHESTRATION SYSTEM IN THE MARKET

Advanced Therapy Medicinal Products

A NEW APPROACH TO ORCHESTRATION

Open orchestration platform providing agnostic data exchange and integration services

Contact Us

IN PARTNERSHIP WITH GLOBAL OT-IT

logo Global OT&IT

Related solutions